Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.630
-0.080 (-4.68%)
At close: Feb 20, 2026, 4:00 PM EST
1.660
+0.030 (1.84%)
After-hours: Feb 20, 2026, 7:13 PM EST
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $243.64 million as of February 20, 2026. Its market cap has increased by 76.17% in one year.
Market Cap
243.64M
Enterprise Value
106.29M
1-Year Change
76.17%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $243.64M, a decrease of -39.72%. That is a compound annual growth rate of -4.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 197.00M | 14.80% |
| Dec 31, 2025 | 171.60M | 7.92% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
| Nov 6, 2014 | 404.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Opus Genetics | 258.62M |
| AC Immune | 257.77M |
| Shattuck Labs | 253.75M |
| Larimar Therapeutics | 252.49M |
| Palisade Bio | 251.82M |
| Inhibikase Therapeutics | 246.21M |
| OmniAb | 246.16M |
| Protalix BioTherapeutics | 239.66M |